Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shahin Lockman

Showing results (1-10 of 268) with videos related to

Pageof 27
Sort By:
Current Opinion in HIV and AIDS|April 18, 2009
Prevention of mother-to-child transmission, drug resistance, and implications for response to therapyShahin Lockman
Current Opinion in HIV and AIDS|January 10, 2012
Treatment-for-prevention: clinical considerationsShahin Lockman, Paul Sax
Current Opinion in HIV and AIDS|August 27, 2019
Reaching 90-90-90 in BotswanaM Essex, Joseph Makhema, Shahin Lockman
Journal of Virological Methods|February 26, 2008
Improvement in allele-specific PCR assay with the use of polymorphism-specific primers for the analysis of minor variant drug resistance in HIV-1 subtype CChristopher F Rowley, Christian L Boutwell, Shahin Lockman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2022
Considerations for the Use of Long-Acting and Extended-Release Agents During Pregnancy and LactationAdeniyi Olagunju, Jyoti Mathad, Ahizechukwu Eke, et al.
The Journal of Infectious Diseases|May 21, 2013
Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomesRoger Paredes, Vincent C Marconi, Shahin Lockman, et al.
AIDS (London, England)|August 29, 2025
Embracing uncertainty in early safety signals: A lesson from the Tsepamo study results describing neural tube defect risk and the use of Dolutegravir (DTG) in pregnancySean S Brummel, Sonja Swanson, Ellen Caniglia, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
SARS-CoV-2 Testing Disparities in MassachusettsScott Dryden-Peterson, Gustavo E Velásquez, Thomas J Stopka, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 30, 2010
Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ARTIain J MacLeod, Christopher F Rowley, Ibou Thior, et al.
Plos One|February 25, 2017
Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan AfricaMosepele Mosepele, Linda C Hemphill, Tommy Palai, et al.
Pageof 27

Showing results (1-10 of 268) with videos related to

Sort By:
Pageof 27
Current Opinion in HIV and AIDS|April 18, 2009
Prevention of mother-to-child transmission, drug resistance, and implications for response to therapyShahin Lockman
Current Opinion in HIV and AIDS|January 10, 2012
Treatment-for-prevention: clinical considerationsShahin Lockman, Paul Sax
Current Opinion in HIV and AIDS|August 27, 2019
Reaching 90-90-90 in BotswanaM Essex, Joseph Makhema, Shahin Lockman
Journal of Virological Methods|February 26, 2008
Improvement in allele-specific PCR assay with the use of polymorphism-specific primers for the analysis of minor variant drug resistance in HIV-1 subtype CChristopher F Rowley, Christian L Boutwell, Shahin Lockman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 21, 2022
Considerations for the Use of Long-Acting and Extended-Release Agents During Pregnancy and LactationAdeniyi Olagunju, Jyoti Mathad, Ahizechukwu Eke, et al.
The Journal of Infectious Diseases|May 21, 2013
Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomesRoger Paredes, Vincent C Marconi, Shahin Lockman, et al.
AIDS (London, England)|August 29, 2025
Embracing uncertainty in early safety signals: A lesson from the Tsepamo study results describing neural tube defect risk and the use of Dolutegravir (DTG) in pregnancySean S Brummel, Sonja Swanson, Ellen Caniglia, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
SARS-CoV-2 Testing Disparities in MassachusettsScott Dryden-Peterson, Gustavo E Velásquez, Thomas J Stopka, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|April 30, 2010
Minor resistant variants in nevirapine-exposed infants may predict virologic failure on nevirapine-containing ARTIain J MacLeod, Christopher F Rowley, Ibou Thior, et al.
Plos One|February 25, 2017
Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan AfricaMosepele Mosepele, Linda C Hemphill, Tommy Palai, et al.
Pageof 27